Business

Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?

Posted on Author admin Comments Off on Congress loves a Big Pharma villain. But will that lead to any real policy changes on drug prices?

AbbVie has never been shy about guarding its patents and hiking drug prices. Congress tore into the company this week. But will it lead to any real policy change? Read More

Related Articles
Business

‘Biden’ stocks Have Been outperforming’Trump’ stocks from 66 Percent since Election Day nears

Posted on Author admin

Our assignment that will assist you browse the new ordinary is fueled by readers. Is your stock exchange gambling on Biden? That could be one decision from a current J.P. Morgan analyst notice taking a look at the current performance of 2 baskets of shares –one full of titles that could succeed beneath a Biden […]
Business COVID 19

Goldman Sachs downgrades GDP estimates for Q4 and beyond thanks to COVID case surge

Posted on Author admin

Goldman Sachs is serving up some harsh projections just days before Thanksgiving. The bank cited “the rapid and broad-based resurgence of the coronavirus” as the main reason it was downgrading Q4 and Q1 GDP forecasts. Goldman now expects +3.5% and +1.0% annualized growth in Q4 and Q1 (+4.5% and +3.5% previously). Indeed, the worry is […]
Business

‘Poorly designed and irresponsibly run’: PPP scrutiny mounts after SBA data dump

Posted on Author admin

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today. In the wake of the court-ordered release of Paycheck Protection Program (PPP) data last week, scrutiny of the Trump administration’s management of the program continues to mount—with one government watchdog describing PPP as “poorly designed […]